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1ERRATUM
Further discussions are necessary on some statements made in 
the text of this dissertation.
Practical applications of the f luorescein-cor. jugated 
an^i-T cell reagent are illustrated by the way the remainder 
of the preparation was used subsequent to completion of this 
work.
With the cooperation of an interested pathologist the 
reagent was used in conjunction with EAC rosettes for E cells 
and EA rosettes for macrophages, to investigate three cases of 
lymphoid neoplasia. Cryostat sections of surgical material 
were examined by the three techniques in parallel. Two cases 
were thereby proved to be of B cell origin with EAC rosette 
distribution and T ce'1 fluorescence being complementary in 
the disturbed architecture of the lymph nodes. The third case 
of splenic material gave an ambiguous distribution pattern 
with both T and B cells increased. A definite diagnosis was 
not made.
These elementary investigations illustrate how useful 
techniques for typing lymphocytes in tissue sections can be. 
Neither EAC rosette formation, nor this particular antiserum 
is capable of identifying individual cells, but more potent 
antisera produced by longer immunisation schedules as 
discussed in the text would overcome this problem as far as 
T cells arc concerned.
The observation on p 77 line 15 that " Complement did not
2appear necessary for anti thymocyte cytotoxicity", is a 
lesson in misinterpretation of the results of an ill-designed 
experiment. The function of complement in the antigen-antibody 
interaction is discussed on p 18 of the text and it is funda­
mental to immunology that the immunoglobulin molecule is not 
capable of cytotoxic function on it's own.
The error occurred during investigations into the cyto­
toxic activity of the ant1-thymocyte antisera. These were 
set up in a standard technique (No. 14, p 56), with comple­
ment included in' the system. A typical result is shown in 
figure 9, p 80, with a plateau of activity to a titre of 1:8 
against viable thymocytes. Thes~ data indicated that the 
antisera were satisfactorily cytotoxic for their specific tar­
get cells, but unfortunately it was decided to investigate the 
role of complement in the system; an enquiry not of particular 
relevance to the overall object of work.
As discussed on pp 28 and 30 the experiences of other 
workers were encountered in the difficulty of obtaining and 
preserving viable thymocytes, particularly from human sources. 
Viable fetuses were rare, and frozen preparations lost 
viability much quicker than lymphatic leukaemia cells or 
peripheral blood lymphocytes. Thus, live thymocytes were used 
with far greater respect and economy.
Shortage of thymocytes was a restrictior: posed in setting 
up the secondary investigation on the vole ot complement. The 
three anti-T cell sera were only tested at a single dilution 
of 1:2 in duplicate, against viable thymocytes. Each serum 
was tested with complement and without complement in the 
system and controls were run to establish cytotoxicity of
complement alone; of inactivated normal rabbit serum, and 
any change in target cell viability during the test.
The results of this experiment were in accordance with 
the statement cn p 77. However, if viable thymocytes had 
been more freely available, and if the investigation had had 
more importance, the antisera would have been tested over a 
range of dilutions to perhaps 1:64. With complement added, 
the results would have been similar to those illustrated in 
fig. 9. Without complement, the cytotoxic index would have 
fallen very quickly on dilution. The dependence of the 
anti-T cell antibodies on complement for full cytotoxic ex- 
pr'-Tsion would have been quite obvious and the ambiguous 
statement would not bive be<- i made. To this effect the follow­
ing lines should be deleted from the text.
p 77 line 15 (from "Complement) to line 22. 
p 105 line 20 (from "Cytotoxicity) to line 24.
SUMMARY
The work describes the attempt to produce rabbit antisera 
capable of demonstrating human T and B cells in tissue sec­
tions by direct fluorescent antibody techniques. Thymus 
cells from therapeutically aborted fetuses, and lymphocytes 
from peripheral blood of patients suffering from chronic lym­
phatic leukaemia were characterised by conventional cell mar­
ker systems and stored as frozen living cells.
Antisera were raised in rabbits 1: / intravenous inoculat­
ions of live cell suspensions. The resulting hyper-immune 
antibodies were recovered and purified as globulin solutions. 
These were examined for cytotoxicity for lymphocyte suspens­
ions by trypan blue exclusion tests. Inhibition of fjncrion 
was studied by exposing normal lympnocytes to the antibodies 
and studying their capability to form sheep rrj cell rosettes.
The most suitable absorbents for removal of non-specific 
reactions were investigated using aliquots of globulin solut­
ions. After bulk absorptions the antibodies were conjugated 
with fluorescein isothiocyanate. Column chromatography through 
Sephadex and DEAE cellulose beds was used to remove free 
fluorochrome and to recover optimally conjugated molecules. 
Fractions of effluent from the columns were subjected to ultra­
violet light spectrophotometry and direct fluorescent antibody 
tests on normal human lymph node and thymus. Those fractions 
showing optimal physico-chemical data and biological perform­
ance were concentrated, pooled and freeze-dried for storage.
Antisera raised with thymus cells yielded a good reager.c, 
cytotoxic for T cells, inhibiting sheep red cell rosette func­
I
tion and staining T ccll membranes in thymus and T cell depen­
dent areas of lymph node.
The anti-B cell reagent,however,was not successful. Anti­
body activity was detected in sera from rabbits inoculated 
with chronic lymphatic leukaemia lymphocytes, but this was 
directed against immunoglobulin itself. It is suggested that 
the membrane surface antigens of £ cells are masked by immuno­
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